CRMDCorMedix Inc.

$518M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26,523-71.3% YoY

Gross Profit

$4,41016.6% margin

Operating Income

$2M8061.8% margin

Net Income

$2M8100.6% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

-92.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$19,019

Balance Sheet

Total Assets

$19M

Total Liabilities

$14M

Stockholders' Equity

-$179M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26,523	$92,526	-71.3%
Gross Profit	$4,410	$29,215	-84.9%
Operating Income	$2M	-$10M	+120.8%
Net Income	$2M	-$10M	+120.8%

CRMD Q4 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena